Articles By Trisha Gladd

51. Global Healthcare Executives Cite Product Security As A Top Concern In 2013 11/13/2013

    Since 2008, UPS has commissioned an annual survey titled “Pain in the (Supply) Chain,” which tracks industry trends by conducting an in-depth phone interview with executives from medical device, pharmaceutical, and biopharma companies. Working with the market research company TNS Global, UPS is able to gain an understanding from companies all over the globe about what the current concerns are, what challenges are being met, and which challenges are being missed.

52. H.R. 3204 Could Emerge From The Serialization “Thunderdome” This Month – Then What? 10/25/2013

    H.R. 3204 Could Emerge From The Serialization “Thunderdome” This Month – Then What?

    What serialization deadlines should the pharma industry be preparing for? Because federal legislation would trump California law, this is the question everyone is asking. And until the Senate passes a track-and-trace bill, it will continue to be a waiting game.

53. Using Innovative Solutions To Address Pharma Manufacturing Challenges 10/17/2013

    Poor supply chain visibility and high costs plague pharmaceutical manufacturers on a daily basis, and with global expansion on the rise, the demand for new technology to address these common industry challenges grows each day. I recently had the opportunity to learn about three innovative technologies created by companies that recognized these areas  in need of improvement and then created a solution that gave their customers what they needed — and a little bit more.

54. A Look At Pack Expo 2013 And The Future Of The Pharma Packaging Trade Show 10/1/2013

    By Trisha Gladd, editor, Pharmaceutical Online and Bioprocess Online

    This year’s Pack Expo was held at the Las Vegas Convention Center from September 23-25, and with so many experts from the pharmaceutical industry planning to attend, my expectations for the show were high. After finishing preparations for interviews, visits, press conferences, and plenty more that the show had to offer, I took off for Sin City with a packed schedule in one hand and gambling money in the other.

55. Making Peace With Plastic Packaging: How Fear Of The Unknown Might Be Pharma's Biggest Hurdle 9/18/2013

    By Trisha Gladd, editor, Pharmaceutical Online and Bioprocess Online

    While there are plenty of advantages of using plastic packaging instead of glass, some pharmaceutical manufacturers still won’t consider it for liquid pharmaceuticals because of the long history and tradition of using glass. However, is this because it’s not a good choice for pharmaceutical packaging or is it because we just don’t know enough?

56. A Shift In Focus: The Value Of Serialization 9/1/2013

    By Trisha Gladd, editor, Pharmaceutical Online and Bioprocess Online

    When it comes to the topic of serialization and California’s 2015 deadline, much of the discussion focuses on cost and compliance. What are the costs associated with preparing your company for California’s ePedigree Law? With a history of delays in this law, as well as a federal mandate, is preparation even necessary?
     

57. Three Ways A Logistics Partnership Can Reduce The Cost Of Global Expansion 8/30/2013

    By Trisha Gladd, editor, Pharmaceutical Online and Bioprocess Online

    In order to meet the needs of an expanding global market, healthcare executives find themselves facing the daunting challenge of not only making their product accessible to foreign markets but also maintaining quality during shipment. I recently spoke with Robin Hooker, director of Global Healthcare Logistics Strategy at UPS, about how a logistics partnership can help reduce the costs associated with these challenges and provide advantages beyond the bottom line.

58. How Reliable Is The Pharma Equipment You Buy? 8/13/2013

    When it comes to equipment manufacturing in the pharmaceutical industry, it is imperative that a product functions exactly as it was intended. Any misstep caused by faulty equipment could have catastrophic results for the company that produces a drug, but more importantly, for the patient who uses it. The serious consequences that can result from a lack of accurate equipment design and the associated manufacturing processes are why Donald Dobert, president and COO of ATL Pharmaceutical/Medical, created his company’s New Product Development (NPD) Planning Process.

59. How Active Packaging Systems Can Provide More Than Temperature Control

    With the cost of cold chain logistics expected to rise from 6.7 billion in 2012 to 10.7 billion in 2017, it is even more important for pharmaceutical manufacturers producing temperature-sensitive drugs to select the most effective packaging solution to ship their product.  

60. A Global Look At Product Protection

    We all know that serialization deadlines are looming.  While some companies have serialization projects underway, others are still waiting to get theirs started. Whatever the situation, there are still many unanswered questions about product protection, both domestically through the Drug Quality and Security Act (DQSA) and internationally through each country's regulations, and some of these answers are very hard to find (while others are still to be determined).

    I recently sat down with two lead serialization consultants from Enterprise System Partners, a global consulting and project engineering company specializing in serialization and MES within the life science industry, to discuss many of the questions they’re receiving from their customers. Liam O’Riordan and Linda Murphy provided some clarity around certain aspects of the legislation and what it means both in the US and globally.